Merck sues to challenge new US drug price program

Merck filed a lawsuit Tuesday challenging a new White House-backed program to limit drug prices, calling the initiative an unconstitutional "extortion" that will harm pharmaceutical innovation.


Examining pediatric clinical studies' underfunding risk

A clinical study with children as participants entails extra costs often omitted in the initial budget. Clinical studies involving children are thus at risk of being undercompensated, new research shows.

Diseases, Conditions, Syndromes

Motor neuron disease treatments a step closer

Research at the University of Queensland could eventually help develop viable treatments—and ultimately a cure—for motor neuron disease (MND).

page 1 from 40